← Open Payments lookup

KASIDY FLINK: Open Payments

NPI 1871248245 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$323 in 18 payments from 13 companies in 2025. Trend: 2023 $193 · 2024 $228 · 2025 $323

Food & beverage: $323
CompanyPaymentsAmount
Novo Nordisk Inc4$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Dexcom, Inc.1$22
Ascensia Diabetes Care Us Inc.1$21
AstraZeneca Pharmaceuticals LP1$19
Axsome Therapeutics, Inc.1$17
Otsuka America Pharmaceutical, Inc.1$16
Organon LLC1$16
SANOFI-AVENTIS U.S. LLC1$15

Products named: Wegovy, CAPLYTA, JARDIANCE, Dexcom G6 Transmitter, Rybelsus, BREZTRI, Symbravo, REXULTI.

Industry payments across NE — which companies pay providers there.